bingo betfred

ALBANY, N.Y. (AP) — Justin Neely's 16 points off the bench led Albany (NY) to a 77-70 victory against Stony Brook on Sunday. Neely also contributed nine rebounds for the Great Danes (8-7). Amar'e Marshall scored 15 points, going 6 of 9 (3 for 6 from 3-point range). Kacper Klaczek had 10 points and shot 4 for 8 (0 for 3 from 3-point range) and 2 of 3 from the free-throw line. Ben Wight led the way for the Seawolves (4-9) with 19 points and seven rebounds. Joseph Octave added 13 points and five steals for Stony Brook. Jared Frey finished with 13 points. Albany (NY) took the lead with 19:30 left in the first half and did not give it up. Marshall led their team in scoring with 10 points in the first half to help put them ahead 36-31 at the break. Albany (NY) used an 8-0 run in the second half to build a 19-point lead at 55-36 with 14:01 left in the half before finishing off the win. Albany (NY) plays Saturday against UMass-Lowell at home, and Stony Brook visits Monmouth on Thursday. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .Israel cracks down on Palestinian citizens who speak out against the war in Gaza UMM AL-FAHM, Israel (AP) — In the year since the war in Gaza broke out, Israel's government has been cracking down on dissent among its Palestinian citizens. Authorities have charged Palestinians with “supporting terrorism” because of posts online or for demonstrating against the war. Activists and rights watchdogs say Palestinians have also lost jobs, been suspended from schools and faced police interrogations. Palestinians make up about 20% of Israel's population. Many feel forced to self-censor out of fear of being jailed and further marginalized in society. Others still find ways to dissent, but carefully. Israel's National Security Ministry counters that, “Freedom of speech is not the freedom to incite.” Israel says rabbi who went missing in the UAE was killed TEL AVIV, Israel (AP) — Israel says the body of an Israeli-Moldovan rabbi who went missing in the United Arab Emirates has been found, citing Emirati authorities. The statement from Prime Minister Benjamin Netanyahu’s office on Sunday said Zvi Kogan was killed, calling it a “heinous antisemitic terror incident.” It said: “The state of Israel will act with all means to seek justice with the criminals responsible for his death." Kogan went missing on Thursday, and there were suspicions he had been kidnapped. His disappearance comes as Iran has been threatening to retaliate against Israel after the two countries traded fire in October. Hezbollah fires more than 180 rockets and other projectiles into Israel, wounding at least 7 BEIRUT (AP) — Hezbollah has fired at least 185 rockets and other projectiles into Israel, wounding seven people in the militant group's heaviest barrage in several days. The attacks in northern and central Israel happened Sunday in response to deadly Israeli strikes in central Beirut on Saturday. Meanwhile, negotiators pressed on with cease-fire efforts to halt the all-out war. Lebanon's military says an Israeli strike on a Lebanese army center in the southwest killed one soldier and wounded 18 others. Israel's military has expressed regret and said its operations are directed solely against the militants. Lebanon’s caretaker prime minister condemned the latest strike as an assault on the U.S.-led cease-fire efforts. The rising price of paying the national debt is a risk for Trump's promises on growth and inflation WASHINGTON (AP) — Donald Trump has big plans for the economy. He also has big debt problem that'll be a hurdle to delivering on those plan. Trump has bold ambitions on tax cuts, tariffs and other programs. But high interest rates and the price of repaying the federal government’s existing debt could limit what he’s able to do. The federal debt stands at roughly $36 trillion, and the spike in inflation after the pandemic has pushed up the government’s borrowing costs such that debt service next year will easily exceed spending on national security. After Trump's Project 2025 denials, he is tapping its authors and influencers for key roles WASHINGTON (AP) — During the campaign, President-elect Donald Trump had hailed what would become Project 2025 as a conservative roadmap for “exactly what our movement will do." Trump pulled an about-face when Project 2025 became a political liability. He denied knowing anything about the “ridiculous and abysmal” plans, even though some were written by his former aides and many allies. Now, after winning the 2024 election, Trump is stocking his second administration with key players in the effort he temporarily shunned. Trump has tapped Russell Vought for an encore as director of the Office of Management and Budget; Tom Homan, his former immigration chief, as “border czar;” and immigration hardliner Stephen Miller as deputy chief of policy. Forecasts warn of possible winter storms across US during Thanksgiving week WINDSOR, Calif. (AP) — Forecasters in the U.S. have warned of another round of winter weather that could complicate travel leading up to Thanksgiving. California is bracing for more snow and rain this weekend while still grappling with some flooding and small landslides from a previous storm. The National Weather Service has issued a winter storm warning for California's Sierra Nevada through Tuesday, with heavy snow expected at high elevations. Thousands remained without power in the Seattle area on Saturday after a “bomb cyclone” storm system hit the West Coast earlier in the week, killing two people. Parts of the Northeast and Appalachia also began the weekend with heavy precipitation. Pakistan partially stops mobile and internet services ahead of pro-Imran Khan protest ISLAMABAD (AP) — Pakistan has suspended mobile and internet services “in areas with security concerns” as supporters of imprisoned former premier Imran Khan gear up for a protest in the capital. The government and Interior Ministry made the announcement on X, which is banned in Pakistan. Sunday's protest is to demand Khan's release. He has been in prison for more than a year but remains popular. His supporters rely heavily on social media and messaging apps to coordinate with each other. Pakistan has already sealed off Islamabad and shut down major roads and highways connecting the city with Khan's power bases. Here's what to know about the new funding deal that countries agreed to at UN climate talks BAKU, Azerbaijan (AP) — In the wee hours Sunday at the United Nations climate talks, countries from around the world reached an agreement on how rich countries can cough up the funds to support poor countries in the face of climate change. But it’s a far-from-perfect arrangement, with many parties still unsatisfied but hopeful that the deal will be a step in the right direction. Japan holds Sado mines memorial despite South Korean boycott amid lingering historical tensions SADO, Japan (AP) — Japan has held a memorial ceremony near the Sado Island Gold Mines despite a last-minute boycott of the event by South Korea that highlighted tensions between the neighbors over the brutal wartime use of Korean laborers. South Korea’s absence at Sunday’s memorial, to which Seoul government officials and Korean victims’ families were invited, is a major setback in the rapidly improving ties between the countries. The Sado mines were listed in July as a UNESCO World Heritage Site after Japan moved past years of disputes with South Korea and reluctantly acknowledged the mines’ dark history. Chuck Woolery, smooth-talking game show host of 'Love Connection' and 'Scrabble,' dies at 83 NEW YORK (AP) — Chuck Woolery, the affable, smooth-talking game show host of “Wheel of Fortune,” “Love Connection” and “Scrabble” who later became a right-wing podcaster, skewering liberals and accusing the government of lying about COVID-19, has died. He was 83. Mark Young, Woolery’s podcast co-host and friend, said in an email early Sunday that Woolery died at his home in Texas with his wife, Kristen, present. Woolery, with his matinee idol looks, coiffed hair and ease with witty banter, was inducted into the American TV Game Show Hall of Fame in 2007 and earned a daytime Emmy nomination in 1978. He teamed up with Young for the podcast “Blunt Force Truth” and became a full supporter Donald Trump.bingo betfred 。

A deal which could see the Elgin Marbles returned to Greece is “still some distance” away, George Osborne has signalled. The former Tory chancellor, now chairman of the British Museum, suggested Sir Keir Starmer had contributed to a warmer spirit of the negotiations over the famous ancient artworks. Greece has long called for the return of the Marbles, also known as the Parthenon sculptures, and maintains they were illegally removed from Athens’ acropolis during a period of foreign occupation. The British Museum – where they are currently on display – is forbidden by law from giving away any of its artefacts, and the Government has no plans to change the law to permit a permanent move. No 10 has indicated the Prime Minister is unlikely to stand in the way of such a deal. Speaking on Political Currency, the podcast he hosts alongside former Labour politician Ed Balls, Mr Osborne said the museum was “looking to see if we can come to some arrangement where at some point some of the sculptures are in Athens, where, of course, they were originally sited”. He added: “And in return, Greece lends us some of its treasures, and we made a lot of progress on that, but we’re still some distance from any kind of agreement.” The Greek government has suggested negotiations with the museum have taken a warmer tone since Labour came to power in the summer. Mr Osborne appeared to concur with this view and praised Sir Keir’s hands-off approach, adding: “It is not the same as Rishi Sunak, who refused to see the Greek prime minister, if you remember, he sort of stood him up. “So it seems to me a more sensible and diplomatic way to proceed.” Mr Mitsotakis has signalled his government is awaiting developments on the negotiations. A diplomatic spat between the Greek leader and Mr Sunak emerged last year when the then-prime minister refused to meet his counterpart. Mr Mitsotakis had compared splitting the Elgin Marbles from those still in Athens to cutting the Mona Lisa in half. The marble statues came from friezes on the 2,500-year-old Parthenon temple and have been displayed at the British Museum for more than 200 years. They were removed by Lord Elgin in the early 19th century when he was British ambassador to the Ottoman Empire. Some of the remaining temple statues are on display in the purpose-built Acropolis Museum in Athens, and Greece has called for the collections to be reunited.

MELBOURNE, Australia and INDIANAPOLIS , Dec. 30, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX250-CDx (Zircaix®[1], 89 Zr- girentuximab) kidney cancer imaging[2]. TLX250-CDx is an investigational PET[3] drug product for the non-invasive diagnosis and characterisation of clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer. If approved, TLX250-CDx will be the first and only targeted PET agent specifically for kidney cancer to be commercially available in the U.S., further building on Telix’s successful urology imaging franchise. The FDA is expected to advise the PDUFA[4] goal date following the 60-day administrative review of the application. Kevin Richardson , Chief Executive Officer, Precision Medicine at Telix, stated, “We are pleased to be progressing the BLA for TLX250-CDx, which has been granted Breakthrough designation, and may therefore be eligible for priority review. Telix continues to target a full U.S. commercial launch in 2025 addressing a major unmet medical need for patients with suspected ccRCC.” About TLX250-CDx TLX250-CDx (Zircaix® 1 ) is an investigational PET agent that is under development for the diagnosis and characterisation of ccRCC. Telix’s pivotal Phase III ZIRCON trial (ClinicalTrials.gov ID: NCT03849118 ) evaluating TLX250-CDx in 300 patients, of whom 284 were evaluable, met all primary and secondary endpoints, including showing 86% sensitivity and 87% specificity and a 93% positive-predictive value for ccRCC across three independent radiology readers[5]. Telix believes this demonstrated the ability of TLX250-CDx to reliably detect the clear cell phenotype and provide an accurate, non-invasive method for diagnosing and characterising ccRCC. Confidence intervals exceeded expectations amongst all three readers, showing evidence of high accuracy and consistency of interpretation. About Telix Pharmaceuticals Limited Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia , with international operations in the United States , Europe ( Belgium and Switzerland ), and Japan . Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX). Telix’s lead imaging product, gallium-68 ( 68 Ga) gozetotide injection (also known as 68 Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA)[6], by the Australian Therapeutic Goods Administration (TGA) [7], and by Health Canada [8] . No other Telix product has received a marketing authorisation in any jurisdiction. Visit www.telixpharma.com for further information about Telix, including details of the latest share price, announcements made to the ASX, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on X and LinkedIn . Telix Investor Relations Ms. Kyahn Williamson Telix Pharmaceuticals Limited SVP Investor Relations and Corporate Communications Email: kyahn.williamson@telixpharma.com This announcement has been authorised for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board. Legal Notices You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our registration statement on Form 20-F filed with the SEC, or on our website. The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States . The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement. This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialisation of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements. ©2024 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Illuccix® and Zircaix® 1 names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. View original content to download multimedia: https://www.prnewswire.com/apac/news-releases/telix-files-tlx250-cdx-zircaix-bla-for-kidney-cancer-imaging-302339972.html SOURCE Telix Pharmaceuticals LimitedCoinbase chief people officer Lawrence Brock sells $8m in stock

The real estate market, a cornerstone of China's economy, has also shown signs of resilience, with property prices in major cities reaching new highs. The ongoing urbanization trend, coupled with robust demand from both homebuyers and investors, has fueled a property boom that shows no signs of slowing down.

Exuding elegance and charm, Pearl Residences has garnered attention for its exquisite design and attention to detail. The project's prime location and upscale features have made it a top choice for discerning buyers.AP News Summary at 10:21 a.m. EST

"We take the safety and security of our passengers very seriously," the statement read. "We are aware of the incident involving a mother and daughter carrying knives on board one of our trains, and we are working closely with the authorities to investigate the matter thoroughly."None

Melbourne, Young Sam Konstas will gradually come to understand the beauty and vagaries of Test cricket, much like Jasprit Bumrah demonstrated to him in the second essay of the Boxing Day Test, following the debutant's fiery first-innings fifty, feels former Australian opener Simon Katich. Katich, who played 56 Tests for Australia between 2001 to 2010, wants Konstas to retain his unconventional batting style as no one expects a 19-year-old to be a finished product. "Look its tough and there is always going to be hype when you have a 19-year-old making debut because he is in rare company at his age," Katich told PTI during an interview. Konstas scored 60 off 65 balls in the first innings. He hit a conventional lap scoop for maximum and pulled off a reverse lap scoop behind square against Bumrah before walking down the track to smash a six over mid-wicket all in one over. However, the world's best fast bowler in contemporary times bowled a perfect off-cutter to clean the debutant up for 8 in the second innings. "What we saw from him in the first innings at the MCG was unbelievable courage, given the conditions he faced and the challenge of playing against arguably the best bowler in the series Jasprit Bumrah. "Yes, he found a way to counter him with the ramp shot. It was unconventional but we know that the game is being played differently now." "In the second innings, Konstas saw that Test cricket is not going to be easy. The conditions always change and you have to deal with Bumrah. "Given he is only 19, no one expects him to be a finisher. He has lots to learn and gain experience, but obviously he's got potential and talent," said the left-hander, who scored 10 Test hundreds for Australia, including a couple against India." Does he find streaks of David Warner in Konstas' aggression, Katich feels that similarity with the just-retired left-hander ends with temperament and gameplan. "There are certainly aspects of temperament and gameplan, modern-age thinking but in terms of style, he is a very different type of player than Warner as Konstas is much taller. He can run towards the bowler, down the track to put them off length. "Not saying Warner can’t do that but different types players, but he should try and be himself throughout his career." Time for selectors to think beyond Marsh ========================= Katich agrees that if Mitchell Marsh isn’t contributing with the ball, then Australia's National Selection Panel will need to have a look at the combination considering the all-rounder's poor returns with the bat. "No doubt Marsh is under pressure because he isn’t bowling so much. Even after Josh Hazlewood got injured, he only bowled two overs on a day when Cummins and Starc had to share the workload." "There were questions, he then missed out with the bat at MCG and hasn't been able to fulfil the role with the ball. The selectors have a decision to make at the end of this Test.” Talking about Mitchell Starc’s dodgy back and a possible replacement, Katich believes it will either be reserves Jhye Richardson or Sean Abbott. However, he marked tall left-arm pacer Spencer Johnson as a future contender, provided he continues to bowl extensively for South Australia. "If they are being consistent, then guys who have come as cover, Jhye Richardson or Sean Abbott will be in the mix. Spencer Johnson is playing in Big Bash League and is coming back after a toe injury. It is one thing bowling four overs in BBL and bowling 22 to 25 overs in a Test match is completely different, backing it up day after day. "Something they will know better with workloads and managements. I do think Spencer is a potential Test player. He has skills and capability but he has to play more matches for South Australia.” Bumrah is best fast bowler now ==================== Having played a considerable amount of cricket against India, Katich considers Jasprit Bumrah one of the best overseas pacers to have travelled Down Under in the last two decades. "No doubt that of all the players I have seen or played against in last 20 odd years, Bumrah's numbers speak for themselves. One that got Alex Carey, the ball was seaming back, knocking down his stumps was an absolute beauty. Young Konstas got one that pegged back and hit top of middle, great control and skill-set to work batsmen out." Asked what makes Bumrah special, Katich said: “Great pace. Yes, he has unique action. The fact that he gets movement both ways and hits the length and an area at will. "He has got great control, yorker, bouncer, length and adjusting lines whether to get an LBW or bowling in the channel to get an outside edge, backed up by his pace.” This article was generated from an automated news agency feed without modifications to text.